Insider Trading › INCY › Insiders
INCYTE CORP
INCY·Nasdaq·
United States·Insider activity
United States·Insider activity$112.73
-1.40 (-1.23%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
INCY
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
INCYS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, INCY insiders filed 0 purchases ($0) and 26 sales ($21.9M) on the open market, by 6 insiders. Newest filing Sep 17, 2026 (20 days ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by INCY insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$21.9MSales · 180 days
1,215Open-market transactions on record
6Insiders filing · 180 days
Purchases (code P) and sales (code S) of INCY common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
1,215 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| CAGNONI PABLO JPresident, Global Head of R&D | Sale | −9,233 | $120.50 | $1.1M | 197.2Kdirect | Sep 15, 2026 | Sep 17, 2026 | Form 4 ↗ |
| CAGNONI PABLO JPresident, Global Head of R&D | Sale | −14.0K | $120.49 | $1.7M | 183.2Kdirect | Sep 15, 2026 | Sep 17, 2026 | Form 4 ↗ |
| CAGNONI PABLO JPresident, Global Head of R&D | Sale | −10.8K | $125.56 | $1.4M | 183.2Kdirect | Aug 19, 2026 | Aug 20, 2026 | Form 4 ↗ |
| CAGNONI PABLO JPresident, Global Head of R&D | Sale | −10.8K | $120.04 | $1.3M | 194.0Kdirect | Aug 12, 2026 | Aug 14, 2026 | Form 4 ↗ |
| Mayes Patrick AEVP & Chief Scientific Officer | Sale | −2,207 | $123.99 | $274K | 61.4Kdirect | Aug 5, 2026 | Aug 7, 2026 | Form 4 ↗ |
| CAGNONI PABLO JPresident, Global Head of R&D | Sale | −10.6K | $122.69 | $1.3M | 204.8Kdirect | Aug 5, 2026 | Aug 7, 2026 | Form 4 ↗ |
| Mayes Patrick AEVP & Chief Scientific Officer | Sale | −6,055 | $120.43 | $729K | 61.4Kdirect | Aug 3, 2026 | Aug 4, 2026 | Form 4 ↗ |
| Mayes Patrick AEVP & Chief Scientific Officer | Sale | −85 | $122.19 | $10K | 64.1Kdirect | Jul 31, 2026 | Aug 4, 2026 | Form 4 ↗ |
| Mayes Patrick AEVP & Chief Scientific Officer | Sale | −6,171 | $119.43 | $737K | 75.0Kdirect | Jul 31, 2026 | Aug 4, 2026 | Form 4 ↗ |
| Mayes Patrick AEVP & Chief Scientific Officer | Sale | −5,332 | $119.42 | $637K | 83.3Kdirect | Jul 31, 2026 | Aug 4, 2026 | Form 4 ↗ |
| Mayes Patrick AEVP & Chief Scientific Officer | Sale | −4,695 | $119.39 | $561K | 70.3Kdirect | Jul 31, 2026 | Aug 4, 2026 | Form 4 ↗ |
| Mayes Patrick AEVP & Chief Scientific Officer | Sale | −326 | $121.69 | $40K | 63.7Kdirect | Jul 31, 2026 | Aug 4, 2026 | Form 4 ↗ |
| Mayes Patrick AEVP & Chief Scientific Officer | Sale | −2,864 | $119.40 | $342K | 67.4Kdirect | Jul 31, 2026 | Aug 4, 2026 | Form 4 ↗ |
| Mayes Patrick AEVP & Chief Scientific Officer | Sale | −2,293 | $119.41 | $274K | 61.4Kdirect | Jul 31, 2026 | Aug 4, 2026 | Form 4 ↗ |
| Mayes Patrick AEVP & Chief Scientific Officer | Sale | −2,187 | $119.47 | $261K | 81.2Kdirect | Jul 31, 2026 | Aug 4, 2026 | Form 4 ↗ |
| Mayes Patrick AEVP & Chief Scientific Officer | Sale | −1,643 | $119.51 | $196K | 65.8Kdirect | Jul 31, 2026 | Aug 4, 2026 | Form 4 ↗ |
| Mayes Patrick AEVP & Chief Scientific Officer | Sale | −1,642 | $119.38 | $196K | 64.1Kdirect | Jul 31, 2026 | Aug 4, 2026 | Form 4 ↗ |
| Mayes Patrick AEVP & Chief Scientific Officer | Sale | −14.7K | $119.46 | $1.8M | 88.7Kdirect | Jul 31, 2026 | Aug 4, 2026 | Form 4 ↗ |
| CAGNONI PABLO JPresident, Global Head of R&D | Sale | −15.9K | $119.70 | $1.9M | 215.4Kdirect | Jul 31, 2026 | Aug 4, 2026 | Form 4 ↗ |
| Issa Mohamed KhairieEVP, Head of U.S. Commercial | Sale | −1,093 | $115.01 | $126K | 63.9Kdirect | Jul 16, 2026 | Jul 20, 2026 | Form 4 ↗ |
| Stein Steven HCMO & Head of Late-Stage Dev. | Sale | −1,877 | $114.73 | $215K | 21.1Kdirect | Jul 16, 2026 | Jul 20, 2026 | Form 4 ↗ |
| Stein Steven HCMO & Head of Late-Stage Dev. | Sale | −28.2K | $113.05 | $3.2M | 26.1Kdirect | Jul 15, 2026 | Jul 16, 2026 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −2,639 | $100.00 | $264K | 21.1Kdirect | Jun 4, 2026 | Jun 8, 2026 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −2,051 | $97.35 | $200K | 21.1Kdirect | May 26, 2026 | May 28, 2026 | Form 4 ↗ |
| Clancy Paul JDirector | Sale | −15.0K | $94.93 | $1.4M | 23.7Kdirect | May 19, 2026 | May 21, 2026 | Form 4 ↗ |
| CAGNONI PABLO JPresident, Global Head of R&D | Sale | −18.7K | $96.50 | $1.8M | 262.7Kdirect | Apr 17, 2026 | Apr 21, 2026 | Form 4 ↗ |
| CAGNONI PABLO JPresident, R&D | Sale | −18.7K | $94.24 | $1.8M | 234.8Kdirect | Mar 17, 2026 | Mar 19, 2026 | Form 4 ↗ |
| CAGNONI PABLO JPresident, R&D | Sale | −18.7K | $100.91 | $1.9M | 234.8Kdirect | Feb 19, 2026 | Feb 23, 2026 | Form 4 ↗ |
| Issa Mohamed KhairieEVP, Head of US Oncology | Sale | −10.9K | $109.07 | $1.2M | 66.1Kdirect | Jan 7, 2026 | Jan 8, 2026 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −15.6K | $101.70 | $1.6M | 34.2Kdirect | Jan 5, 2026 | Jan 7, 2026 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −2,774 | $100.00 | $277K | 23.0Kdirect | Dec 19, 2025 | Dec 22, 2025 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −600 | $98.25 | $59K | 23.0Kdirect | Dec 18, 2025 | Dec 22, 2025 | Form 4 ↗ |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Sale | −4,323 | $97.26 | $420K | 27.5Kdirect | Dec 17, 2025 | Dec 18, 2025 | Form 4 ↗ |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Sale | −53.2K | $97.29 | $5.2M | 31.8Kdirect | Dec 16, 2025 | Dec 18, 2025 | Form 4 ↗ |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Sale | −833 | $97.42 | $81K | 85.0Kdirect | Dec 16, 2025 | Dec 18, 2025 | Form 4 ↗ |
| Mayes Patrick AEVP & Chief Scientific Officer | Sale | −255 | $94.94 | $24K | 60.0Kdirect | Dec 11, 2025 | Dec 12, 2025 | Form 4 ↗ |
| Mayes Patrick AEVP & Chief Scientific Officer | Sale | −5,553 | $95.58 | $531K | 60.3Kdirect | Dec 10, 2025 | Dec 12, 2025 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −20.1K | $102.51 | $2.1M | 63.1Kdirect | Dec 2, 2025 | Dec 3, 2025 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −2,559 | $102.96 | $263K | 100.3Kdirect | Dec 1, 2025 | Dec 3, 2025 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −600 | $103.00 | $62K | 23.6Kdirect | Nov 24, 2025 | Nov 25, 2025 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −169 | $102.00 | $17K | 24.2Kdirect | Nov 21, 2025 | Nov 25, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −278 | $104.36 | $29K | 26.6Kdirect | Nov 17, 2025 | Nov 19, 2025 | Form 4 ↗ |
| Hoppenot HerveDirector | Sale | −187.5K | $105.46 | $19.8M | 329.6Kdirect | Nov 10, 2025 | Nov 12, 2025 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −5,233 | $102.20 | $535K | 102.9Kdirect | Nov 5, 2025 | Nov 7, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −598 | $101.36 | $61K | 26.6Kdirect | Nov 4, 2025 | Nov 6, 2025 | Form 4 ↗ |
| Heeson LeeEVP, Head of Incyte Intl | Sale | −3,074 | $94.02 | $289K | 29.2Kdirect | Nov 3, 2025 | Nov 5, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −277 | $85.13 | $24K | 26.6Kdirect | Oct 15, 2025 | Oct 17, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −3,501 | $85.54 | $299K | 26.6Kdirect | Oct 3, 2025 | Oct 6, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −599 | $87.65 | $53K | 33.2Kdirect | Oct 2, 2025 | Oct 6, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −278 | $83.15 | $23K | 33.2Kdirect | Sep 16, 2025 | Sep 18, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −598 | $84.97 | $51K | 33.2Kdirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −277 | $86.81 | $24K | 33.2Kdirect | Aug 15, 2025 | Aug 19, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −598 | $75.77 | $45K | 33.2Kdirect | Aug 4, 2025 | Aug 6, 2025 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −3,706 | $67.94 | $252K | 102.9Kdirect | Jul 21, 2025 | Jul 23, 2025 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −1,340 | $68.36 | $92K | 35.1Kdirect | Jul 16, 2025 | Jul 17, 2025 | Form 4 ↗ |
| Iyengar Vijay KEVP, GMAPPS | Sale | −983 | $68.36 | $67K | 40.5Kdirect | Jul 16, 2025 | Jul 17, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −785 | $68.36 | $54K | 33.2Kdirect | Jul 16, 2025 | Jul 17, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −3,330 | $69.86 | $233K | 26.5Kdirect | Jul 15, 2025 | Jul 17, 2025 | Form 4 ↗ |
| Iyengar Vijay KEVP, GMAPPS | Sale | −1,177 | $69.86 | $82K | 35.9Kdirect | Jul 15, 2025 | Jul 16, 2025 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −1,192 | $69.86 | $83K | 37.6Kdirect | Jul 15, 2025 | Jul 16, 2025 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −15.0K | $68.47 | $1.0M | 97.5Kdirect | Jul 14, 2025 | Jul 16, 2025 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −10.9K | $68.15 | $743K | 39.7Kdirect | Jul 3, 2025 | Jul 7, 2025 | Form 4 ↗ |
| Iyengar Vijay KEVP, GMAPPS | Sale | −5,935 | $68.15 | $404K | 37.7Kdirect | Jul 3, 2025 | Jul 7, 2025 | Form 4 ↗ |
| Iyengar Vijay KEVP, GMAPPS | Sale | −2,682 | $68.16 | $183K | 43.6Kdirect | Jul 3, 2025 | Jul 7, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −599 | $68.61 | $41K | 26.5Kdirect | Jul 2, 2025 | Jul 7, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −1,795 | $68.00 | $122K | 26.5Kdirect | Jun 3, 2025 | Jun 5, 2025 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −651 | $64.88 | $42K | 22.0Kdirect | Jun 2, 2025 | Jun 3, 2025 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −963 | $65.71 | $63K | 22.7Kdirect | May 30, 2025 | Jun 3, 2025 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −19.1K | $67.68 | $1.3M | 33.6Kdirect | Mar 14, 2025 | Mar 18, 2025 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −199 | $67.88 | $14K | 52.7Kdirect | Mar 14, 2025 | Mar 18, 2025 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −461 | $67.85 | $31K | 52.9Kdirect | Mar 14, 2025 | Mar 18, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −599 | $69.99 | $42K | 25.8Kdirect | Mar 4, 2025 | Mar 6, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −4,495 | $74.08 | $333K | 25.8Kdirect | Feb 26, 2025 | Feb 28, 2025 | Form 4 ↗ |
| Denton Sheila A.EVP & General Counsel | Sale | −9,574 | $74.07 | $709K | 30.3Kdirect | Feb 26, 2025 | Feb 28, 2025 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −12.4K | $72.69 | $898K | 67.0Kdirect | Jan 21, 2025 | Jan 22, 2025 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −650 | $69.31 | $45K | 23.3Kdirect | Dec 16, 2024 | Dec 17, 2024 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −650 | $70.64 | $46K | 24.0Kdirect | Dec 13, 2024 | Dec 17, 2024 | Form 4 ↗ |
| Iyengar Vijay KEVP, GMAPPS | Sale | −5,683 | $75.37 | $428K | 30.7Kdirect | Nov 29, 2024 | Dec 3, 2024 | Form 4 ↗ |
| Iyengar Vijay KEVP, GMAPPS | Sale | −360 | $75.60 | $27K | 36.3Kdirect | Nov 29, 2024 | Dec 3, 2024 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −2,256 | $78.21 | $176K | 58.0Kdirect | Nov 6, 2024 | Nov 8, 2024 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −1,424 | $82.00 | $117K | 60.3Kdirect | Nov 6, 2024 | Nov 8, 2024 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −382 | $63.37 | $24K | 24.4Kdirect | Sep 13, 2024 | Sep 16, 2024 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −572 | $62.94 | $36K | 24.8Kdirect | Sep 12, 2024 | Sep 16, 2024 | Form 4 ↗ |
| Dickinson Jonathan ElliottEVP, General Manager, Europe | Sale | −7,333 | $62.37 | $457K | 36.4Kdirect | Sep 12, 2024 | Sep 16, 2024 | Form 4 ↗ |
| Dickinson Jonathan ElliottEVP, General Manager, Europe | Sale | −1,117 | $62.30 | $70K | 43.7Kdirect | Sep 12, 2024 | Sep 16, 2024 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −11.6K | $60.63 | $704K | 90.0Kdirect | Aug 12, 2024 | Aug 14, 2024 | Form 4 ↗ |
| Iyengar Vijay KEVP, GMAPPS | Sale | −15.6K | $70.00 | $1.1M | 36.7Kdirect | Jul 25, 2024 | Jul 29, 2024 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −1,306 | $64.19 | $84K | 58.0Kdirect | Jul 16, 2024 | Jul 17, 2024 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −8,148 | $60.00 | $489K | 50.5Kdirect | Jul 9, 2024 | Jul 11, 2024 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −19.2K | $60.00 | $1.1M | 66.4Kdirect | Jun 12, 2024 | Jun 14, 2024 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −1,093 | $58.91 | $64K | 21.6Kdirect | Jun 6, 2024 | Jun 10, 2024 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −7,365 | $65.51 | $482K | 90.2Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Iyengar Vijay KEVP, GMAPPS | Sale | −657 | $65.00 | $43K | 43.4Kdirect | Jan 2, 2024 | Jan 4, 2024 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −1,067 | $62.37 | $67K | 23.4Kdirect | Dec 13, 2023 | Dec 14, 2023 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −210 | $57.36 | $12K | 24.5Kdirect | Dec 12, 2023 | Dec 14, 2023 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −8,449 | $65.13 | $550K | 77.5Kdirect | Sep 1, 2023 | Sep 6, 2023 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −21.5K | $63.28 | $1.4M | 97.6Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −802 | $84.06 | $67K | 68.5Kdirect | Jan 31, 2023 | Feb 2, 2023 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −4,842 | $84.73 | $410K | 68.5Kdirect | Jan 30, 2023 | Feb 1, 2023 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −5,644 | $85.07 | $480K | 68.5Kdirect | Jan 30, 2023 | Feb 1, 2023 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −14.4K | $84.73 | $1.2M | 68.5Kdirect | Jan 30, 2023 | Feb 1, 2023 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −11.9K | $84.70 | $1.0M | 68.5Kdirect | Jan 30, 2023 | Feb 1, 2023 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −10.4K | $84.70 | $884K | 68.5Kdirect | Jan 30, 2023 | Feb 1, 2023 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −12.9K | $84.69 | $1.1M | 68.5Kdirect | Jan 30, 2023 | Feb 1, 2023 | Form 4 ↗ |
| Iyengar Vijay KEVP, GMAPPS | Sale | −7,000 | $85.00 | $595K | 42.8Kdirect | Jan 26, 2023 | Jan 30, 2023 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −2,419 | $85.00 | $206K | 53.3Kdirect | Jan 26, 2023 | Jan 30, 2023 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −28.4K | $79.78 | $2.3M | 109.0Kdirect | Jan 4, 2023 | Jan 6, 2023 | Form 4 ↗ |
| Iyengar Vijay KEVP, GMAPPS | Sale | −1,654 | $80.79 | $134K | 37.9Kdirect | Dec 23, 2022 | Dec 28, 2022 | Form 4 ↗ |
| Iyengar Vijay KEVP, GMAPPS | Sale | −804 | $80.77 | $65K | 39.5Kdirect | Dec 23, 2022 | Dec 28, 2022 | Form 4 ↗ |
| Iyengar Vijay KEVP, GMAPPS | Sale | −7,000 | $80.80 | $566K | 40.3Kdirect | Dec 23, 2022 | Dec 28, 2022 | Form 4 ↗ |
| Iyengar Vijay KEVP, GMAPPS | Sale | −7,866 | $80.80 | $636K | 40.3Kdirect | Dec 23, 2022 | Dec 28, 2022 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −1,223 | $82.16 | $100K | 16.6Kdirect | Dec 19, 2022 | Dec 21, 2022 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −1,564 | $83.13 | $130K | 17.7Kdirect | Jul 22, 2022 | Jul 26, 2022 | Form 4 ↗ |
| Iyengar Vijay KEVP, GMAPPS | Sale | −5,787 | $79.38 | $459K | 40.3Kdirect | Jul 7, 2022 | Jul 11, 2022 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −2,873 | $79.38 | $228K | 72.7Kdirect | Jul 7, 2022 | Jul 11, 2022 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −1,248 | $82.96 | $104K | 65.2Kdirect | Apr 8, 2022 | Apr 12, 2022 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −881 | $82.96 | $73K | 66.4Kdirect | Apr 8, 2022 | Apr 12, 2022 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −21.3K | $84.00 | $1.8M | 67.3Kdirect | Apr 8, 2022 | Apr 12, 2022 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −20.5K | $83.01 | $1.7M | 67.3Kdirect | Apr 8, 2022 | Apr 12, 2022 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +175.8K | $73.31 | $12.9M | 33.4Mindirect | Mar 10, 2022 | Mar 10, 2022 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +14.5K | $73.31 | $1.1M | 2.9Mindirect | Mar 10, 2022 | Mar 10, 2022 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +1,017 | $71.95 | $73K | 33.2Mindirect | Mar 10, 2022 | Mar 10, 2022 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +84 | $71.95 | $6K | 2.9Mindirect | Mar 10, 2022 | Mar 10, 2022 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +25.1K | $71.90 | $1.8M | 33.2Mindirect | Mar 10, 2022 | Mar 10, 2022 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +2,070 | $71.90 | $149K | 2.9Mindirect | Mar 10, 2022 | Mar 10, 2022 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +65.1K | $71.72 | $4.7M | 33.2Mindirect | Mar 9, 2022 | Mar 10, 2022 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +5,370 | $71.72 | $385K | 2.9Mindirect | Mar 9, 2022 | Mar 10, 2022 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +92.4K | $70.68 | $6.5M | 33.2Mindirect | Mar 8, 2022 | Mar 10, 2022 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +7,615 | $70.68 | $538K | 2.9Mindirect | Mar 8, 2022 | Mar 10, 2022 | Form 4 ↗ |
| BAKER FELIXDirector · 10% owner | Purchase | +92.2K | $68.07 | $6.3M | 33.0Mindirect | Feb 22, 2022 | Feb 22, 2022 | Form 4 ↗ |
| BAKER FELIXDirector · 10% owner | Purchase | +7,566 | $68.07 | $515K | 2.9Mindirect | Feb 22, 2022 | Feb 22, 2022 | Form 4 ↗ |
| BAKER FELIXDirector · 10% owner | Purchase | +22.2K | $68.43 | $1.5M | 32.9Mindirect | Feb 18, 2022 | Feb 22, 2022 | Form 4 ↗ |
| BAKER FELIXDirector · 10% owner | Purchase | +1,827 | $68.43 | $125K | 2.9Mindirect | Feb 18, 2022 | Feb 22, 2022 | Form 4 ↗ |
| BAKER FELIXDirector · 10% owner | Purchase | +100.7K | $68.37 | $6.9M | 32.9Mindirect | Feb 18, 2022 | Feb 22, 2022 | Form 4 ↗ |
| BAKER FELIXDirector · 10% owner | Purchase | +8,296 | $68.37 | $567K | 2.9Mindirect | Feb 18, 2022 | Feb 22, 2022 | Form 4 ↗ |
| BAKER FELIXDirector · 10% owner | Purchase | +285.7K | $67.74 | $19.4M | 32.8Mindirect | Feb 17, 2022 | Feb 22, 2022 | Form 4 ↗ |
| BAKER FELIXDirector · 10% owner | Purchase | +7,300 | $67.40 | $492K | 32.5Mindirect | Feb 17, 2022 | Feb 22, 2022 | Form 4 ↗ |
| BAKER JULIANDirector · 10% owner | Purchase | +182.3K | $66.04 | $12.0M | 32.5Mindirect | Feb 14, 2022 | Feb 14, 2022 | Form 4 ↗ |
| BAKER JULIANDirector · 10% owner | Purchase | +320.5K | $66.02 | $21.2M | 32.3Mindirect | Feb 14, 2022 | Feb 14, 2022 | Form 4 ↗ |
| BAKER JULIANDirector · 10% owner | Purchase | +11.0K | $66.95 | $735K | 32.0Mindirect | Feb 11, 2022 | Feb 14, 2022 | Form 4 ↗ |
| BAKER JULIANDirector · 10% owner | Purchase | +265.5K | $66.81 | $17.7M | 32.0Mindirect | Feb 11, 2022 | Feb 14, 2022 | Form 4 ↗ |
| BAKER JULIANDirector · 10% owner | Purchase | +772.8K | $67.54 | $52.2M | 31.8Mindirect | Feb 10, 2022 | Feb 14, 2022 | Form 4 ↗ |
| BAKER JULIANDirector · 10% owner | Purchase | +6,100 | $67.20 | $410K | 31.0Mindirect | Feb 10, 2022 | Feb 14, 2022 | Form 4 ↗ |
| BAKER JULIANDirector · 10% owner | Purchase | +40.2K | $66.57 | $2.7M | 31.0Mindirect | Feb 10, 2022 | Feb 14, 2022 | Form 4 ↗ |
| Dickinson Jonathan ElliottEVP, General Manager, Europe | Sale | −7,375 | $74.19 | $547K | 30.2Kdirect | Jan 31, 2022 | Feb 2, 2022 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −10.9K | $73.31 | $797K | 72.4Kdirect | Jan 7, 2022 | Jan 11, 2022 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −9,319 | $73.46 | $685K | 72.4Kdirect | Jan 4, 2022 | Jan 5, 2022 | Form 4 ↗ |
| Trower PaulPrincipal Accounting Officer | Sale | −1,396 | $73.31 | $102K | 32.3Kdirect | Jan 3, 2022 | Jan 5, 2022 | Form 4 ↗ |
| Trower PaulPrincipal Accounting Officer | Sale | −6,818 | $73.31 | $500K | 32.3Kdirect | Jan 3, 2022 | Jan 5, 2022 | Form 4 ↗ |
| DIXON WENDY LDirector | Sale | −20.0K | n/c | — | 17.3Kdirect | Dec 23, 2021 | Dec 27, 2021 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +194.0K | $72.91 | $14.1M | 30.9Mindirect | Dec 17, 2021 | Dec 17, 2021 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +881.9K | $72.77 | $64.2M | 30.7Mindirect | Dec 17, 2021 | Dec 17, 2021 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +29.7K | $72.00 | $2.1M | 29.9Mindirect | Dec 16, 2021 | Dec 17, 2021 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +139.6K | $71.96 | $10.0M | 29.8Mindirect | Dec 16, 2021 | Dec 17, 2021 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +288.4K | $71.91 | $20.7M | 29.7Mindirect | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +5,382 | $71.03 | $382K | 29.4Mindirect | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +9,893 | $70.24 | $695K | 29.4Mindirect | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +36.5K | $69.63 | $2.5M | 29.4Mindirect | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +9,352 | $68.52 | $641K | 29.3Mindirect | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| 667, L.P.Director · 10% owner | Purchase | +861 | $67.90 | $58K | 29.3Mindirect | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −389 | $68.67 | $27K | 31.3Kdirect | Oct 1, 2021 | Oct 4, 2021 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −388 | $76.71 | $30K | 31.7Kdirect | Sep 1, 2021 | Sep 3, 2021 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −389 | $77.49 | $30K | 32.0Kdirect | Aug 2, 2021 | Aug 4, 2021 | Form 4 ↗ |
| Iyengar Vijay KEVP GPS, BD, & Licensing | Sale | −4,911 | $78.29 | $384K | 27.0Kdirect | Jul 29, 2021 | Aug 2, 2021 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −396 | $84.09 | $33K | 26.1Kdirect | Jul 1, 2021 | Jul 2, 2021 | Form 4 ↗ |
| Wenqing YaoEVP, Head of Discovery Chem | Sale | −27.2K | $85.37 | $2.3M | 94.1Kdirect | Jun 29, 2021 | Jun 30, 2021 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −3,845 | $87.00 | $335K | 26.5Kdirect | Jun 10, 2021 | Jun 14, 2021 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −395 | $84.13 | $33K | 26.5Kdirect | Jun 1, 2021 | Jun 3, 2021 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −396 | $85.40 | $34K | 26.9Kdirect | May 3, 2021 | May 5, 2021 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −396 | $81.57 | $32K | 27.3Kdirect | Apr 1, 2021 | Apr 5, 2021 | Form 4 ↗ |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Sale | −20.0K | $81.08 | $1.6M | 45.5Kdirect | Mar 29, 2021 | Mar 31, 2021 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −395 | $79.73 | $31K | 27.7Kdirect | Mar 1, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Hoppenot HerveChairman / CEO · Director | Purchase | +12.9K | $77.37 | $1.0M | 284.2Kdirect | Feb 23, 2021 | Feb 23, 2021 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −395 | $90.00 | $36K | 28.1Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −961 | $90.00 | $86K | 28.5Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| Wenqing YaoEVP, Head of Discovery Chem | Sale | −20.0K | $100.00 | $2.0M | 143.8Kdirect | Jan 25, 2021 | Jan 27, 2021 | Form 4 ↗ |
| Wenqing YaoEVP, Head of Discovery Chem | Sale | −1,559 | $100.00 | $156K | 143.8Kdirect | Jan 25, 2021 | Jan 27, 2021 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −3,795 | $100.00 | $380K | 119.7Kdirect | Jan 25, 2021 | Jan 27, 2021 | Form 4 ↗ |
| Iyengar Vijay KEVP GPS, BD, & Licensing | Sale | −1,000 | $99.00 | $99K | 26.2Kdirect | Jan 25, 2021 | Jan 27, 2021 | Form 4 ↗ |
| Iyengar Vijay KEVP GPS, BD, & Licensing | Sale | −4,116 | $99.00 | $407K | 27.2Kdirect | Jan 25, 2021 | Jan 27, 2021 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −2,744 | $100.00 | $274K | 50.0Kdirect | Jan 25, 2021 | Jan 27, 2021 | Form 4 ↗ |
| BIENAIME JEAN JACQUESDirector | Sale | −798 | $83.00 | $66K | 8,646direct | Nov 10, 2020 | Nov 12, 2020 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −961 | $85.17 | $82K | 28.0Kdirect | Nov 6, 2020 | Nov 10, 2020 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −20.0K | $86.60 | $1.7M | 40.0Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −1,423 | $95.00 | $135K | 28.3Kdirect | Oct 9, 2020 | Oct 13, 2020 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −961 | $91.97 | $88K | 28.0Kdirect | Oct 6, 2020 | Oct 8, 2020 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −2,193 | $90.83 | $199K | 28.2Kdirect | Sep 10, 2020 | Sep 14, 2020 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −961 | $88.94 | $85K | 28.0Kdirect | Sep 8, 2020 | Sep 10, 2020 | Form 4 ↗ |
| DIXON WENDY LDirector | Sale | −20.0K | $94.51 | $1.9M | 14.2Kdirect | Aug 27, 2020 | Aug 31, 2020 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −961 | $97.80 | $94K | 28.0Kdirect | Aug 6, 2020 | Aug 10, 2020 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −766 | $103.83 | $80K | 95.5Kdirect | Jul 16, 2020 | Jul 17, 2020 | Form 4 ↗ |
| Iyengar Vijay KEVP GPS, BD, & Licensing | Sale | −475 | $108.56 | $52K | 25.9Kdirect | Jul 8, 2020 | Jul 8, 2020 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −610 | $108.56 | $66K | 96.9Kdirect | Jul 8, 2020 | Jul 8, 2020 | Form 4 ↗ |
| Iyengar Vijay KEVP GPS, BD, & Licensing | Sale | −3,120 | $107.98 | $337K | 26.4Kdirect | Jul 7, 2020 | Jul 8, 2020 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −3,283 | $107.99 | $355K | 97.5Kdirect | Jul 7, 2020 | Jul 8, 2020 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −7,495 | $110.04 | $825K | 100.8Kdirect | Jul 7, 2020 | Jul 8, 2020 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −3,381 | $110.04 | $372K | 100.8Kdirect | Jul 7, 2020 | Jul 8, 2020 | Form 4 ↗ |
| Hoppenot HerveChairman / CEO · Director | Sale | −88.4K | $110.00 | $9.7M | 266.5Kdirect | Jul 7, 2020 | Jul 7, 2020 | Form 4 ↗ |
| Hoppenot HerveChairman / CEO · Director | Sale | −1,365 | $110.00 | $150K | 266.5Kdirect | Jul 7, 2020 | Jul 7, 2020 | Form 4 ↗ |
| Wenqing YaoEVP, Head of Discovery Chem | Sale | −15.6K | $107.32 | $1.7M | 156.3Kdirect | Jul 6, 2020 | Jul 7, 2020 | Form 4 ↗ |
| Wenqing YaoEVP, Head of Discovery Chem | Sale | −905 | $107.32 | $97K | 156.3Kdirect | Jul 6, 2020 | Jul 7, 2020 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −10.4K | $107.31 | $1.1M | 100.8Kdirect | Jul 6, 2020 | Jul 7, 2020 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −10.4K | $107.31 | $1.1M | 100.8Kdirect | Jul 6, 2020 | Jul 7, 2020 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −12.1K | $107.31 | $1.3M | 100.8Kdirect | Jul 6, 2020 | Jul 7, 2020 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −596 | $107.31 | $64K | 100.8Kdirect | Jul 6, 2020 | Jul 7, 2020 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −2,522 | $106.40 | $268K | 100.8Kdirect | Jul 6, 2020 | Jul 7, 2020 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −961 | $106.58 | $102K | 25.6Kdirect | Jul 6, 2020 | Jul 7, 2020 | Form 4 ↗ |
| Hoppenot HerveChairman / CEO · Director | Sale | −119.5K | $102.91 | $12.3M | 240.6Kdirect | Jun 26, 2020 | Jun 30, 2020 | Form 4 ↗ |
| Hoppenot HerveChairman / CEO · Director | Sale | −4,647 | $102.91 | $478K | 240.6Kdirect | Jun 26, 2020 | Jun 30, 2020 | Form 4 ↗ |
| Trower PaulPrincipal Accounting Officer | Sale | −6,943 | $110.00 | $764K | 21.7Kdirect | Jun 23, 2020 | Jun 25, 2020 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −400 | $110.00 | $44K | 36.1Kdirect | Jun 23, 2020 | Jun 25, 2020 | Form 4 ↗ |
| Dickinson Jonathan ElliottEVP, General Manager, Europe | Sale | −9,000 | $105.31 | $948K | 21.8Kdirect | Jun 22, 2020 | Jun 23, 2020 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −1,423 | $100.00 | $142K | 23.7Kdirect | Jun 19, 2020 | Jun 23, 2020 | Form 4 ↗ |
| Iyengar Vijay KEVP GPS, BD, & Licensing | Sale | −7,866 | $105.00 | $826K | 24.9Kdirect | Jun 19, 2020 | Jun 23, 2020 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −7,181 | $105.00 | $754K | 35.9Kdirect | Jun 19, 2020 | Jun 23, 2020 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −2,192 | $94.19 | $206K | 23.5Kdirect | Jun 10, 2020 | Jun 12, 2020 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −1,423 | $95.00 | $135K | 23.5Kdirect | Jun 10, 2020 | Jun 12, 2020 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −961 | $91.87 | $88K | 20.0Kdirect | Jun 8, 2020 | Jun 10, 2020 | Form 4 ↗ |
| Baker Bros. Advisors (GP) LLCDirector · 10% owner | Purchase | +1 | $102.55 | $103 | 29.3Mindirect | May 28, 2020 | May 28, 2020 | Form 4 ↗ |
| Baker Bros. Advisors (GP) LLCDirector · 10% owner | Purchase | +1 | $102.55 | $103 | 2.8Mindirect | May 28, 2020 | May 28, 2020 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −961 | $96.84 | $93K | 20.0Kdirect | May 6, 2020 | May 8, 2020 | Form 4 ↗ |
| Trower PaulPrincipal Accounting Officer | Sale | −1,143 | $100.00 | $114K | 21.3Kdirect | Apr 17, 2020 | Apr 21, 2020 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −6,583 | $100.00 | $658K | 35.3Kdirect | Apr 17, 2020 | Apr 21, 2020 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −9,488 | $100.00 | $949K | 22.9Kdirect | Apr 17, 2020 | Apr 20, 2020 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −9,488 | $95.00 | $901K | 22.9Kdirect | Apr 16, 2020 | Apr 20, 2020 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −17.8K | $90.00 | $1.6M | 22.9Kdirect | Apr 14, 2020 | Apr 15, 2020 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −965 | $85.68 | $83K | 22.9Kdirect | Apr 13, 2020 | Apr 15, 2020 | Form 4 ↗ |
| Pasquale Maria EEVP & General Counsel | Sale | −1,842 | $85.00 | $157K | 24.3Kdirect | Apr 6, 2020 | Apr 8, 2020 | Form 4 ↗ |
| Dhanak DashyantEVP & Chief Scientific Officer | Sale | −3,844 | $85.00 | $327K | 20.0Kdirect | Apr 6, 2020 | Apr 8, 2020 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −690 | $71.44 | $49K | 48.5Kdirect | Mar 31, 2020 | Apr 2, 2020 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −1,639 | $71.44 | $117K | 48.5Kdirect | Mar 31, 2020 | Apr 2, 2020 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −2,500 | $80.00 | $200K | 48.5Kdirect | Feb 19, 2020 | Feb 21, 2020 | Form 4 ↗ |
| Wenqing YaoEVP, Head of Discovery Chem | Sale | −17.5K | $75.97 | $1.3M | 95.3Kdirect | Feb 5, 2020 | Feb 7, 2020 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −2,500 | $81.12 | $203K | 41.6Kdirect | Jan 15, 2020 | Jan 17, 2020 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −2,500 | $91.61 | $229K | 41.6Kdirect | Dec 16, 2019 | Dec 18, 2019 | Form 4 ↗ |
| Wenqing YaoEVP, Head of Discovery Chem | Sale | −16.8K | $95.00 | $1.6M | 95.3Kdirect | Dec 2, 2019 | Dec 3, 2019 | Form 4 ↗ |
| Iyengar Vijay KEVP GPS, BD, & Licensing | Sale | −7,366 | $95.00 | $700K | 17.6Kdirect | Dec 2, 2019 | Dec 3, 2019 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −6,582 | $95.00 | $625K | 17.0Kdirect | Dec 2, 2019 | Dec 3, 2019 | Form 4 ↗ |
| Wenqing YaoEVP, Head of Discovery Chem | Sale | −3,165 | $95.00 | $301K | 95.3Kdirect | Nov 29, 2019 | Dec 3, 2019 | Form 4 ↗ |
| Iyengar Vijay KEVP GPS, BD, & Licensing | Sale | −500 | $95.00 | $48K | 17.6Kdirect | Nov 29, 2019 | Dec 3, 2019 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −600 | $95.00 | $57K | 17.0Kdirect | Nov 29, 2019 | Dec 3, 2019 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −1,720 | $90.00 | $155K | 17.0Kdirect | Nov 25, 2019 | Nov 26, 2019 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −422 | $90.00 | $38K | 17.0Kdirect | Nov 25, 2019 | Nov 26, 2019 | Form 4 ↗ |
| Wenqing YaoEVP, Head of Discovery Chem | Sale | −15.0K | $90.00 | $1.4M | 95.3Kdirect | Nov 25, 2019 | Nov 26, 2019 | Form 4 ↗ |
| Trower PaulPrincipal Accounting Officer | Sale | −15.0K | $90.00 | $1.4M | 17.3Kdirect | Nov 25, 2019 | Nov 26, 2019 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −2,500 | $86.46 | $216K | 41.6Kdirect | Nov 15, 2019 | Nov 19, 2019 | Form 4 ↗ |
| DIXON WENDY LDirector | Sale | −18.3K | $83.87 | $1.5M | 12.3Kdirect | Nov 8, 2019 | Nov 8, 2019 | Form 4 ↗ |
| DIXON WENDY LDirector | Sale | −22.9K | $83.87 | $1.9M | 12.3Kdirect | Nov 8, 2019 | Nov 8, 2019 | Form 4 ↗ |
| DIXON WENDY LDirector | Sale | −1,540 | $83.60 | $129K | 12.3Kdirect | Nov 7, 2019 | Nov 8, 2019 | Form 4 ↗ |
| DIXON WENDY LDirector | Sale | −10.6K | $84.16 | $890K | 12.3Kdirect | Nov 6, 2019 | Nov 8, 2019 | Form 4 ↗ |
| Wenqing YaoEVP, Head of Discovery Chem | Sale | −7,960 | $85.00 | $677K | 95.3Kdirect | Nov 1, 2019 | Nov 5, 2019 | Form 4 ↗ |
| Trower PaulPrincipal Accounting Officer | Sale | −8,500 | $85.00 | $723K | 17.3Kdirect | Nov 1, 2019 | Nov 5, 2019 | Form 4 ↗ |
| Wenqing YaoEVP, Head of Discovery Chem | Sale | −2,040 | $85.00 | $173K | 45.3Kdirect | Oct 29, 2019 | Oct 31, 2019 | Form 4 ↗ |
| Trower PaulPrincipal Accounting Officer | Sale | −1,500 | $85.00 | $128K | 17.3Kdirect | Oct 29, 2019 | Oct 31, 2019 | Form 4 ↗ |
| Trower PaulPrincipal Accounting Officer | Sale | −8,399 | $80.00 | $672K | 17.3Kdirect | Oct 29, 2019 | Oct 31, 2019 | Form 4 ↗ |
| Trower PaulPrincipal Accounting Officer | Sale | −6,601 | $80.00 | $528K | 17.3Kdirect | Oct 29, 2019 | Oct 31, 2019 | Form 4 ↗ |
| Iyengar Vijay KEVP GPS, BD, & Licensing | Sale | −930 | $85.00 | $79K | 17.6Kdirect | Oct 29, 2019 | Oct 31, 2019 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −2,500 | $80.00 | $200K | 41.6Kdirect | Oct 22, 2019 | Oct 24, 2019 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −2,500 | $80.00 | $200K | 41.6Kdirect | Sep 18, 2019 | Sep 19, 2019 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −2,491 | $77.71 | $194K | 16.8Kdirect | Sep 17, 2019 | Sep 19, 2019 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −2,500 | $80.96 | $202K | 41.6Kdirect | Aug 15, 2019 | Aug 19, 2019 | Form 4 ↗ |
| FRIEDMAN PAUL ADirector | Sale | −77.9K | $82.20 | $6.4M | 255.5Kdirect | Aug 6, 2019 | Aug 6, 2019 | Form 4 ↗ |
| FRIEDMAN PAUL ADirector | Sale | −22.1K | $84.41 | $1.9M | 255.5Kdirect | Aug 2, 2019 | Aug 6, 2019 | Form 4 ↗ |
| BIENAIME JEAN JACQUESDirector | Sale | −377 | $84.73 | $32K | 7,055direct | Aug 2, 2019 | Aug 5, 2019 | Form 4 ↗ |
| BIENAIME JEAN JACQUESDirector | Sale | −1,347 | $85.16 | $115K | 7,432direct | Aug 1, 2019 | Aug 5, 2019 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −959 | $79.91 | $77K | 19.2Kdirect | Jul 17, 2019 | Jul 18, 2019 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −2,500 | $80.00 | $200K | 42.3Kdirect | Jul 15, 2019 | Jul 16, 2019 | Form 4 ↗ |
| Stein Steven HEVP & Chief Medical Officer | Sale | −8,357 | $87.96 | $735K | 10.8Kdirect | Jun 24, 2019 | Jun 25, 2019 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −2,500 | $80.00 | $200K | 36.5Kdirect | Jun 17, 2019 | Jun 18, 2019 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −8,218 | $87.01 | $715K | 36.5Kdirect | Apr 1, 2019 | Apr 2, 2019 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −1,782 | $87.01 | $155K | 36.5Kdirect | Apr 1, 2019 | Apr 2, 2019 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −10.0K | $86.68 | $867K | 36.5Kdirect | Mar 1, 2019 | Mar 5, 2019 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −10.0K | $81.19 | $812K | 31.1Kdirect | Feb 1, 2019 | Feb 5, 2019 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −1,000 | $80.00 | $80K | 8,944direct | Jan 28, 2019 | Jan 30, 2019 | Form 4 ↗ |
| Wenqing YaoEVP, Head of Discovery Chem | Sale | −15.4K | $77.61 | $1.2M | 34.4Kdirect | Jan 17, 2019 | Jan 22, 2019 | Form 4 ↗ |
| Trower PaulPrincipal Accounting Officer | Sale | −5,813 | $75.00 | $436K | 13.9Kdirect | Jan 15, 2019 | Jan 17, 2019 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −1,714 | $75.56 | $130K | 9,944direct | Jan 8, 2019 | Jan 10, 2019 | Form 4 ↗ |
| Wenqing YaoEVP, Head of Discovery Chem | Sale | −10.0K | $75.00 | $750K | 35.2Kdirect | Jan 7, 2019 | Jan 8, 2019 | Form 4 ↗ |
| Trower PaulPrincipal Accounting Officer | Sale | −9,187 | $75.00 | $689K | 14.2Kdirect | Jan 7, 2019 | Jan 8, 2019 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −30.0K | $70.00 | $2.1M | 32.3Kdirect | Jan 4, 2019 | Jan 8, 2019 | Form 4 ↗ |
| BIENAIME JEAN JACQUESDirector | Purchase | +500 | $68.91 | $34K | 6,668direct | Nov 8, 2018 | Nov 9, 2018 | Form 4 ↗ |
| BIENAIME JEAN JACQUESDirector | Purchase | +500 | $68.62 | $34K | 6,168direct | Nov 8, 2018 | Nov 9, 2018 | Form 4 ↗ |
| Trower PaulPrincipal Accounting Officer | Sale | −10.0K | $70.00 | $700K | 14.2Kdirect | Oct 3, 2018 | Oct 5, 2018 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −10.0K | $70.00 | $700K | 32.3Kdirect | Oct 3, 2018 | Oct 5, 2018 | Form 4 ↗ |
| Flannelly Barry PEVP & General Manager US | Sale | −1,000 | $70.00 | $70K | 12.4Kdirect | Oct 3, 2018 | Oct 5, 2018 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −10.0K | $73.21 | $732K | 32.3Kdirect | Sep 4, 2018 | Sep 6, 2018 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −10.0K | $70.00 | $700K | 32.3Kdirect | Aug 21, 2018 | Aug 22, 2018 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −10.0K | $71.11 | $711K | 33.0Kdirect | Jul 9, 2018 | Jul 11, 2018 | Form 4 ↗ |
| Iyengar Vijay KEVP GPS, BD, & Licensing | Sale | −606 | $71.34 | $43K | 8,103direct | Jul 9, 2018 | Jul 11, 2018 | Form 4 ↗ |
| Hoppenot HerveChairman / CEO · Director | Purchase | +15.0K | $60.94 | $914K | 276.7Kdirect | May 2, 2018 | May 3, 2018 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −73.9K | $62.43 | $4.6M | 33.4Kdirect | Apr 30, 2018 | May 2, 2018 | Form 4 ↗ |
| SWAIN PAULA JEVP, Human Resources | Sale | −6,100 | $62.43 | $381K | 33.4Kdirect | Apr 30, 2018 | May 2, 2018 | Form 4 ↗ |
| GRYSKA DAVID WExecutive Vice President, CFO | Sale | −1,952 | $85.56 | $167K | 11.0Kdirect | Feb 21, 2018 | Feb 22, 2018 | Form 4 ↗ |
| Huber Reid MEVP, Chief Scientific Officer | Sale | −1,958 | $85.55 | $168K | 35.2Kdirect | Feb 21, 2018 | Feb 22, 2018 | Form 4 ↗ |
| GRYSKA DAVID WExecutive Vice President, CFO | Sale | −6,760 | $98.87 | $668K | 14.0Kdirect | Jan 5, 2018 | Jan 9, 2018 | Form 4 ↗ |
| Iyengar Vijay KEVP GPS, BD, & Licensing | Sale | −5,000 | $97.26 | $486K | 8,676direct | Jan 2, 2018 | Jan 3, 2018 | Form 4 ↗ |
| Huber Reid MEVP, Chief Scientific Officer | Sale | −696 | $98.01 | $68K | 38.2Kdirect | Dec 1, 2017 | Dec 5, 2017 | Form 4 ↗ |
| FRIEDMAN PAUL ADirector | Sale | −28.5K | $105.24 | $3.0M | 269.0Kdirect | Nov 16, 2017 | Nov 20, 2017 | Form 4 ↗ |
| GRYSKA DAVID WExecutive Vice President, CFO | Sale | −3,915 | $105.63 | $414K | 14.0Kdirect | Nov 2, 2017 | Nov 3, 2017 | Form 4 ↗ |
| Hoppenot HerveChairman / CEO · Director | Sale | −70.5K | $119.45 | $8.4M | 299.0Kdirect | Sep 18, 2017 | Sep 20, 2017 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →